Your browser doesn't support javascript.
loading
Hyperammonemia in Inherited Metabolic Diseases.
Ribas, Graziela Schmitt; Lopes, Franciele Fátima; Deon, Marion; Vargas, Carmen Regla.
Afiliação
  • Ribas GS; Departamento de Análises Clínicas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. grazielaribas@yahoo.com.br.
  • Lopes FF; Serviço de Genética Médica, Hospital de Clíinicas de Porto Alegre, Ramiro Barcelos, 2350, Porto Alegre, RS, CEP 90035-003, Brazil. grazielaribas@yahoo.com.br.
  • Deon M; Serviço de Genética Médica, Hospital de Clíinicas de Porto Alegre, Ramiro Barcelos, 2350, Porto Alegre, RS, CEP 90035-003, Brazil.
  • Vargas CR; Serviço de Genética Médica, Hospital de Clíinicas de Porto Alegre, Ramiro Barcelos, 2350, Porto Alegre, RS, CEP 90035-003, Brazil.
Cell Mol Neurobiol ; 42(8): 2593-2610, 2022 Nov.
Article em En | MEDLINE | ID: mdl-34665389
Ammonia is a neurotoxic compound which is detoxified through liver enzymes from urea cycle. Several inherited or acquired conditions can elevate ammonia concentrations in blood, causing severe damage to the central nervous system due to the toxic effects exerted by ammonia on the astrocytes. Therefore, hyperammonemic patients present potentially life-threatening neuropsychiatric symptoms, whose severity is related with the hyperammonemia magnitude and duration, as well as the brain maturation stage. Inherited metabolic diseases caused by enzymatic defects that compromise directly or indirectly the urea cycle activity are the main cause of hyperammonemia in the neonatal period. These diseases are mainly represented by the congenital defects of urea cycle, classical organic acidurias, and the defects of mitochondrial fatty acids oxidation, with hyperammonemia being more severe and frequent in the first two groups mentioned. An effective and rapid treatment of hyperammonemia is crucial to prevent irreversible neurological damage and it depends on the understanding of the pathophysiology of the diseases, as well as of the available therapeutic approaches. In this review, the mechanisms underlying the hyperammonemia and neurological dysfunction in urea cycle disorders, organic acidurias, and fatty acids oxidation defects, as well as the therapeutic strategies for the ammonia control will be discussed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperamonemia / Doenças Metabólicas Tipo de estudo: Diagnostic_studies Limite: Humans / Newborn Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperamonemia / Doenças Metabólicas Tipo de estudo: Diagnostic_studies Limite: Humans / Newborn Idioma: En Ano de publicação: 2022 Tipo de documento: Article